APPILI THERAPEUTICS INC-CL A (APLI.CA) Stock Income Statement
TSX:APLI - Toronto Stock Exchange - CA03783R1073 - Common Stock - Currency: CAD
| TTM (2024-12-31) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 124.80K | 100.40K | 827.40K | 330.00K | 1.39M | |||
| Gross Profit | N/A | N/A | N/A | N/A | 1.39M | |||
| Operating Expenses | 10.09M | 8.77M | 8.88M | 8.25M | 26.01M | |||
| Research and Development | 7.38M | 7.32M | 5.62M | 3.62M | 20.74M | |||
| Selling, General, and Administrative Expenses | 2.70M | 2.85M | 3.25M | 4.60M | 5.26M | |||
| Operating Income | -9.97M | -8.67M | -8.05M | -7.91M | -24.62M | |||
| Interest Income/Expense | -3.24M | -3.83M | -1.55M | -1.43M | -1.52M | |||
| Other Income/Expense | 9.25M | 9.89M | 5.89M | 140.00K | 1.06M | |||
| Income Before Taxes | -3.96M | -2.61M | -3.71M | -9.21M | -25.08M | |||
| Income Tax | N/A | 18.80K | 69.60K | 40.00K | 40.00K | |||
| Net Income | -3.96M | -2.62M | -3.78M | -9.24M | -25.12M | |||
| EBITDA | -9.95M | -8.66M | -8.04M | -7.90M | -24.61M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.03 | -0.02 | -0.03 | -0.08 | -0.38 | |||
| Non GAAP EPS | N/A | N/A | N/A | -0.08 | -0.40 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | 100.00% | |||
| Profit Margin | -3170.03% | -2614.24% | -456.96% | -2800.00% | -1807.19% | |||
| Operating Profit Margin | -7987.10% | -8635.56% | -972.95% | -2396.97% | -1771.22% | |||
All data in CAD